Stephane Giraudier
Overview
Explore the profile of Stephane Giraudier including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
102
Citations
1944
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Beauverd Y, Ianotto J, Thaw K, Sobas M, Sadjadian P, Curto-Garcia N, et al.
Leukemia
. 2025 Mar;
PMID: 40074852
Essential thrombocythemia (ET) and polycythemia vera (PV) are rare in adolescent and young adult (AYA). These conditions, similar to those in older patients, are linked with thrombotic complications and the...
2.
Ganesan S, Awan-Toor S, Guidez F, Maslah N, Rahimy R, Aoun C, et al.
JCI Insight
. 2024 Oct;
9(23).
PMID: 39470742
Despite the advances in the understanding and treatment of myeloproliferative neoplasm (MPN), the disease remains incurable with the risk of evolution to acute myeloid leukemia or myelofibrosis (MF). Unfortunately, the...
3.
Aoun C, Maslah N, Ganesan S, Salomao N, Gendron R, Awan Toor S, et al.
J Cell Mol Med
. 2024 Oct;
28(20):e70138.
PMID: 39431551
Myeloproliferative neoplasms (MPNs) are characterized by an increased production of blood cells due to the acquisition of mutations such as JAK2. TGF-β, whose secretion is increased in MPN patients, is...
4.
Maslah N, Rety S, Bonnamy M, Aguinaga L, Huynh T, Parietti V, et al.
Leukemia
. 2024 May;
38(7):1630-1633.
PMID: 38777834
No abstract available.
5.
Voirin E, Bouvier A, Plo I, Durix L, Beucher A, Giraudier S, et al.
Am J Hematol
. 2024 May;
99(8):1644-1646.
PMID: 38752375
No abstract available.
6.
Galtier J, Drevon L, Le Bris Y, Giraudier S, Wemeau M, Legros L, et al.
Haematologica
. 2024 Feb;
109(6):1989-1993.
PMID: 38328854
No abstract available.
7.
Guerra M, Pasquer H, Daltro de Oliveira R, Soret-Dulphy J, Maslah N, Zhao L, et al.
Am J Hematol
. 2024 Jan;
99(4):741-744.
PMID: 38279562
Comparative clinical characteristics, molecular landscape and prognosis scoring for primary (PMF) and secondary myelofibrosis (SMF).
8.
Gou P, Liu D, Ganesan S, Lauret E, Maslah N, Parietti V, et al.
Blood Cancer J
. 2024 Jan;
14(1):1.
PMID: 38177095
Classical myeloproliferative neoplasms (MPNs) are characterized by the proliferation of myeloid cells and the risk of transformation into myelofibrosis or acute myeloid leukemia (AML) and TP53 mutations in MPN patients...
9.
Pasquer H, Daltro de Oliveira R, Vasseur L, Soret-Dulphy J, Maslah N, Zhao L, et al.
Leukemia
. 2023 Dec;
38(2):326-339.
PMID: 38148396
Current recommended risk scores to predict thrombotic events associated with myeloproliferative neoplasms (MPN) do not discriminate between arterial and venous thrombosis despite their different physiopathology. To define novel stratification systems,...
10.
Elessa D, Zhao L, Daltro de Oliveira R, Maslah N, Soret-Dulphy J, Verger E, et al.
Leukemia
. 2023 Jul;
37(8):1741-1744.
PMID: 37433887
No abstract available.